Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Icotinib
Trade Name
Synonyms BPI-2009|BPI-2009H|Conmana
Drug Descriptions

Icotinib (BPI-2009) is a selective EGFR inhibitor that inhibits both wild-type and mutant forms of EGFR, which may result in decreased tumor cell proliferation (PMID: 22112293).

DrugClasses EGFR Inhibitor 1st gen 3
CAS Registry Number 610798-31-7
NCIT ID C138996


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Icotinib Bevacizumab Icotinib 0 0
Brigatinib + Cetuximab + Icotinib Brigatinib Cetuximab Icotinib 0 0
Crizotinib + Icotinib Crizotinib Icotinib 0 0
Icotinib Icotinib 0 1
Icotinib + Osimertinib Icotinib Osimertinib 0 0
Icotinib + Radiotherapy Icotinib Radiotherapy 0 0

Additional content available in CKB BOOST